RedHill Biopharma’s $39 Million Underwritten Public Offering

Gornitzky represented the underwriters, led by Roth Capital Partners, in RedHill Biopharma’s USD 39 million underwritten public offering of American Depositary Shares (ADSs) and warrants on…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Michael Patrini.

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here